Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer
Published in: Journal of Gastrointestinal Cancer 4/2017

01-12-2017 | Review Article

A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer

Authors: Atousa Haghi, Haniye Azimi, Roja Rahimi

Published in: Journal of Gastrointestinal Cancer | Issue 4/2017

Login to get access

Abstract

Objective

Gastric cancer is one of the most common causes of cancer-related death worldwide. Medicinal plants are one of the main sources for discovery of new pharmacological agents especially for treatment of cancers. The aim of the present study is to review pharmacotherapeutic aspects of three mostly studied phytochemicals including curcumin, quercetin, and allicin for management of gastric cancer.

Methods

Scopus, PubMed, Web of Science, and Google Scholar were searched for the effects of curcumin, quercetin, allicin, and their analogs in gastric cancer. Data were collected up to November 2015. The search terms were “curcumin,” “quercetin,” “allicin,” and “gastric cancer” or “cancer.”

Results

Curcumin demonstrated anti-angiogenic, anti-proliferative, anti-metastatic, pro-apoptotic, and anti-helicobacter activities. Quercetin inhibited cell growth and induced apoptosis, necrosis, and autophagy as well as anti-Helicobacter activity. Allicin showed apoptotic and anti-Helicobacter properties. All three natural compounds had low bioavailability.

Conclusions

Although preclinical studies demonstrated the activity of curcumin, quercetin, and allicin in gastric cancer, clinical trials are needed to confirm their effectiveness. Applying their possible synergistic action and suitable drug delivery system in clinical studies can be also an attractive approach with the purpose of finding new extremely efficient anti-gastric cancer agents.

Mini-Abstract

Curcumin, quercetin, and allicin seem to be good candidates for management of gastric cancer through their pro-apoptotic, anti-proliferative, and anti-helicobacter activities.
Literature
1.
2.
McLean MH, El-Omar EM. Genetics of gastric cancer. Nat Rev Gastroenterol Hepatol. 2014;
3.
Romano M, Ricci V, Zarrilli R. Mechanisms of disease: Helicobacter pylori-related gastric carcinogenesis—implications for chemoprevention. Nat Clin Pract Gastroenterol Hepatol. 2006;3:622–32.CrossRefPubMed
4.
Peek RM, Blaser MJ. Helicobacter pylori and gastrointestinal tract adenocarcinomas. Nat Rev Cancer. 2002;2:28–37.CrossRefPubMed
5.
Tsai H-F, Hsu P-N. Interplay between Helicobacter pylori and immune cells in immune pathogenesis of gastric inflammation and mucosal pathology. Cell Mol Immunol. 2010;7:255–9.CrossRefPubMedPubMedCentral
6.
7.
Crawford HC, Krishna US, Israel DA, et al. Helicobacter pylori strain-selective induction of matrix metalloproteinase-7 in vitro and within gastric mucosa. Gastroenterology. 2003;125:1125–36.CrossRefPubMed
8.
Lee SY, Shin YW, Hahm KB. Phytoceuticals: mighty but ignored weapons against Helicobacter pylori infection. J Dig Dis. 2008;9:129–39.CrossRefPubMed
9.
Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15:195–218.CrossRefPubMed
10.
Boughan PK, Argent RH, Body-Malapel M, et al. Nucleotide-binding oligomerization domain-1 and epidermal growth factor receptor critical regulators of β-defensins during Helicobacter pylori infection. J Biol Chem. 2006;281:11637–48.CrossRefPubMed
11.
Yan F, Cao H, Chaturvedi R, et al. Epidermal growth factor receptor activation protects gastric epithelial cells from Helicobacter pylori-induced apoptosis. Gastroenterology. 2009;136:1297–307. e3.CrossRefPubMedPubMedCentral
12.
Wong BC, Zhang L, Ma J-l, et al. Effects of selective COX-2 inhibitor and Helicobacter pylori eradication on precancerous gastric lesions. Gut 2011:gutjnl-2011-300154.
13.
Wu C-Y, Wang C-J, Tseng C-C, et al. Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway. World J Gastroenterol. 2005;11:3197.CrossRefPubMedPubMedCentral
14.
Keates S, Keates AC, Katchar K, et al. Helicobacter pylori induces up-regulation of the epidermal growth factor receptor in AGS gastric epithelial cells. J Infect Dis. 2007;196:95–103.CrossRefPubMed
15.
Li J, Shen L, Lu F-r, et al. Plumbagin inhibits cell growth and potentiates apoptosis in human gastric cancer cells in vitro through the NF-κB signaling pathway. Acta Pharmacol Sin. 2012;33:242–9.CrossRefPubMedPubMedCentral
16.
Yu L-L, Wu J-G, Dai N, et al. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor. Oncol Rep. 2011;26:1197.PubMed
17.
Dorai T, Aggarwal BB. Role of chemopreventive agents in cancer therapy. Cancer Lett. 2004;215:129–40.CrossRefPubMed
18.
Karin M, Cao Y, Greten FR, et al. NF-κB in cancer: from innocent bystander to major culprit. Nat Rev Cancer. 2002;2:301–10.CrossRefPubMed
19.
Ema A, Yamashita K, Sakuramoto S, et al. Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy. Gastric Cancer. 2014;17:67–75.CrossRefPubMed
20.
Sarkar FH, Li Y, Wang Z, et al. Lesson learned from nature for the development of novel anti-cancer agents: implication of isoflavone, curcumin, and their synthetic analogs. Curr Pharm Des. 2010;16:1801.CrossRefPubMedPubMedCentral
21.
Aqil F, Munagala R, Jeyabalan J, et al. Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett. 2013;334:133–41.CrossRefPubMedPubMedCentral
22.
Koosirirat C, Linpisarn S, Changsom D, et al. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients. Int Immunopharmacol. 2010;10:815–8.CrossRefPubMed
23.
Peng Y-m, Zheng J-b, Zhou Y-b, et al. Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-κB signaling pathway with distinct mechanisms. Acta Pharmacol Sin. 2013;34:939–50.CrossRefPubMedPubMedCentral
24.
Shehzad A, Wahid F, Lee YS. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm. 2010;343:489–99.CrossRef
25.
Duvoix A, Blasius R, Delhalle S, et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005;223:181–90.CrossRefPubMed
26.
Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-κB–regulated gene products. Cancer Res. 2007;67:3853–61.CrossRefPubMed
27.
Foryst-Ludwig A, Neumann M, Schneider-Brachert W, et al. Curcumin blocks NF-κB and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem Biophys Res Commun. 2004;316:1065–72.CrossRefPubMed
28.
Woo J-H, Kim Y-H, Choi Y-J, et al. Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt. Carcinogenesis. 2003;24:1199–208.CrossRefPubMed
29.
Shehzad A, Khan S, Shehzad O, et al. Curcumin therapeutic promises and bioavailability in colorectal cancer. Drugs of Today. 2010;46:523.CrossRefPubMed
30.
Kuttan G, Kumar KBH, Guruvayoorappan C, et al. Antitumor, anti-invasion, and antimetastatic effects of curcumin. The molecular targets and therapeutic uses of curcumin in health and disease. Springer; 2007. p. 173–84.
31.
Amagase H. Clarifying the real bioactive constituents of garlic. J Nutr. 2006;136:716S–25S.PubMed
32.
Xue X, Yu J-L, Sun D-Q, et al. Curcumin induces apoptosis in SGC-7901 gastric adenocarcinoma cells via regulation of mitochondrial signaling pathways. Asian Pac J Cancer Prev. 2014;15:3987–92.CrossRefPubMed
33.
Cai X-Z, Wang J, Xiao-Dong L, et al. Curcumin suppresses proliferation and invasion in human gastric cancer cells by down-regulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther. 2009;8:1360–8.CrossRefPubMed
34.
Cao A-L, Tang Q-F, Zhou W-C, et al. Ras/ERK signaling pathway is involved in curcumin-induced cell cycle arrest and apoptosis in human gastric carcinoma AGS cells. J Asian Nat Prod Res 2014:1–8.
35.
36.
Singletary K, Milner J. Diet, autophagy, and cancer: a review. Cancer Epidemiol Biomark Prev. 2008;17:1596–610.CrossRef
37.
38.
Zhang S-F, Wang X-L, Yang X-Q, et al. Autophagy-associated targeting pathways of natural products during cancer treatment. Asian Pac J Cancer Prev: APJCP. 2014;15:10557.CrossRefPubMed
39.
Sintara K, Thong-Ngam D, Patumraj S, et al. Curcumin suppresses gastric NF-κB activation and macromolecular leakage in Helicobacter pylori-infected rats. World J Gastroenterol: WJG. 2010;16:4039.CrossRefPubMedPubMedCentral
40.
Shaikh J, Ankola D, Beniwal V, et al. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur J Pharm Sci. 2009;37:223–30.CrossRefPubMed
41.
Anand P, Kunnumakkara AB, Newman RA, et al. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4:807–18.CrossRefPubMed
42.
Zhang L, Kong Y, Wu D, et al. Three flavonoids targeting the β-hydroxyacyl-acyl carrier protein dehydratase from Helicobacter pylori: crystal structure characterization with enzymatic inhibition assay. Protein Sci. 2008;17:1971–8.CrossRefPubMedPubMedCentral
43.
Dajas F. Life or death: neuroprotective and anticancer effects of quercetin. J Ethnopharmacol. 2012;143:383–96.CrossRefPubMed
44.
Chen C, Zhou J, Ji C. Quercetin: a potential drug to reverse multidrug resistance. Life Sci. 2010;87:333–8.CrossRefPubMed
45.
Dutta KR, Banerjee S, Mitra A. Medicinal plants of West Midnapore, India: emphasis on phytochemical containment having role on oral cancer. Int J Phytopharmacol. 2012;3:198–208.
46.
Bi Y, Shen C, Li C, et al. Inhibition of autophagy induced by quercetin at a late stage enhances cytotoxic effects on glioma cells. Tumor Biol. 2015:1–12.
47.
Jeong JH, An JY, Kwon YT, et al. Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression. J Cell Biochem. 2009;106:73–82.CrossRefPubMedPubMedCentral
48.
Hu X-T, Ding C, Zhou N, et al. Quercetin protects gastric epithelial cell from oxidative damage in vitro and in vivo. Eur J Pharmacol. 2015;
49.
Bishayee K, Ghosh S, Mukherjee A, et al. Quercetin induces cytochrome-c release and ROS accumulation to promote apoptosis and arrest the cell cycle in G2/M, in cervical carcinoma: signal cascade and drug-DNA interaction. Cell Prolif. 2013;46:153–63.CrossRefPubMed
50.
Borska S, Chmielewska M, Wysocka T, et al. In vitro effect of quercetin on human gastric carcinoma: targeting cancer cells death and MDR. Food Chem Toxicol. 2012;50:3375–83.CrossRefPubMed
51.
Gibellini L, Pinti M, Nasi M, et al. Quercetin and cancer chemoprevention. Evidence-based complementary and alternative medicine 2011;2011.
52.
Ekström A, Serafini M, Nyren O, et al. Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden. Ann Oncol. 2011;22:438–43.CrossRefPubMed
53.
Nguyen T, Tran E, Nguyen T, et al. The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis. 2004;25:647–59.CrossRefPubMed
54.
Rivera AR, Castillo-Pichardo L, Gerena Y, et al. Anti-breast cancer potential of quercetin via the Akt/AMPK/mammalian target of rapamycin (mTOR) signaling cascade. PLoS One. 2016;11:e0157251.CrossRef
55.
Ranelletti FO, Ricci R, Larocca LM, et al. Growth-inhibitory effect of quercetin and presence of type-II estrogen-binding sites in human colon-cancer cell lines and primary colorectal tumors. Int J Cancer. 1992;50:486–92.CrossRefPubMed
56.
Shen X, Si Y, Wang Z, et al. Quercetin inhibits the growth of human gastric cancer stem cells by inducing mitochondrial-dependent apoptosis through the inhibition of PI3K/Akt signaling. Int J Mol Med. 2016;
57.
Wang P, Zhang K, Zhang Q, et al. Effects of quercetin on the apoptosis of the human gastric carcinoma cells. Toxicol in Vitro. 2012;26:221–8.CrossRefPubMed
58.
González-Segovia R, Quintanar JL, Salinas E, et al. Effect of the flavonoid quercetin on inflammation and lipid peroxidation induced by Helicobacter pylori in gastric mucosa of guinea pig. J Gastroenterol. 2008;43:441–7.CrossRefPubMed
59.
Psahoulia FH, Moumtzi S, Roberts ML, et al. Quercetin mediates preferential degradation of oncogenic Ras and causes autophagy in Ha-RAS-transformed human colon cells. Carcinogenesis. 2007;28:1021–31.CrossRefPubMed
60.
Wang K, Liu R, Li J, et al. Quercetin induces protective autophagy in gastric cancer cells: involvement of Akt-mTOR-and hypoxia-induced factor 1α-mediated signaling. Autophagy. 2011;7:966–78.CrossRefPubMed
61.
Wiczkowski W, Romaszko J, Bucinski A, et al. Quercetin from shallots (Allium cepa L. var. aggregatum) is more bioavailable than its glucosides. J Nutr. 2008;138:885–8.PubMed
62.
Chakraborty S, Stalin S, Das N, et al. The use of nano-quercetin to arrest mitochondrial damage and MMP-9 upregulation during prevention of gastric inflammation induced by ethanol in rat. Biomaterials. 2012;33:2991–3001.CrossRefPubMed
63.
Bat-Chen W, Golan T, Peri I, et al. Allicin purified from fresh garlic cloves induces apoptosis in colon cancer cells via Nrf2. Nutr Cancer. 2010;62:947–57.CrossRefPubMed
64.
Borlinghaus J, Albrecht F, Gruhlke MC, et al. Allicin: chemistry and biological properties. Molecules. 2014;19:12591–618.CrossRefPubMed
65.
Zhang Z-m, Zhong N, Gao H-q, et al. Inducing apoptosis and upregulation of Bax and Fas ligand expression by allicin in hepatocellular carcinoma in Balb/c nude mice. Chin Med J-Beijing-Engl Ed. 2006;119:422.
66.
Cha JH, Choi YJ, Cha SH, et al. Allicin inhibits cell growth and induces apoptosis in U87MG human glioblastoma cells through an ERK-dependent pathway. Oncol Rep. 2012;28:41–8.PubMed
67.
Park B, Kim K, Rhee D-K, et al. The apoptotic effect of allicin in MCF-7 human breast cancer cells: role for ATF3. The FASEB J. 2012;2012
68.
Park S-Y, Cho S-J, H-c K, et al. Caspase-independent cell death by allicin in human epithelial carcinoma cells: involvement of PKA. Cancer Lett. 2005;224:123–32.CrossRefPubMed
69.
Tao M, Gao L, Pan J, et al. Study on the inhibitory effect of allicin on human gastric cancer cell line sgc-7901 and its mechanism. Afr J Tradit Complement Altern Med. 2013;11:176–9.PubMedPubMedCentral
70.
Yang JY, Della-Fera MA, Nelson-Dooley C, et al. Molecular mechanisms of apoptosis induced by ajoene in 3T3-L1 adipocytes. Obesity. 2006;14:388–97.CrossRefPubMed
71.
Chu Y-L, Ho C-T, Chung J-G, et al. Allicin induces p53-mediated autophagy in Hep G2 human liver cancer cells. J Agric Food Chem. 2012;60:8363–71.CrossRefPubMed
72.
73.
Sivam GP. Protection against Helicobacter pylori and other bacterial infections by garlic. J Nutr. 2001;131:1106S–8S.PubMed
74.
O'Gara EA, Hill DJ, Maslin DJ. Activities of garlic oil, garlic powder, and their diallyl constituents against Helicobacter pylori. Appl Environ Microbiol. 2000;66:2269–73.CrossRefPubMedPubMedCentral
75.
Takeuchi H, Trang VT, Morimoto N, et al. Natural products and food components with anti-Helicobacter pylori activities. World J Gastroenterol: WJG. 2014;20:8971.PubMedPubMedCentral
76.
Nicastro HL, Ross SA, Milner JA. Garlic and onions: their cancer prevention properties. Cancer Prev Res 2015:canprevres. 0172.2014.
77.
Vazquez-Prieto MA, Miatello RM. Organosulfur compounds and cardiovascular disease. Mol Asp Med. 2010;31:540–5.CrossRef
78.
Alpers DH. Garlic and its potential for prevention of colorectal cancer and other conditions. Curr Opin Gastroenterol. 2009;25:116–21.CrossRefPubMed
79.
Iciek M, Kwiecień I, Włodek L. Biological properties of garlic and garlic-derived organosulfur compounds. Environ Mol Mutagen. 2009;50:247–65.CrossRefPubMed
80.
Lu Q, Lu P-M, Piao J-H, et al. Preparation and physicochemical characteristics of an allicin nanoliposome and its release behavior. LWT-Food Sci Technol. 2014;57:686–95.CrossRef
81.
82.
Kunnumakkara AB, Anand P, Aggarwal BB. Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 2008;269:199–225.CrossRefPubMed
83.
Dolcet X, Llobet D, Pallares J, et al. NF-kB in development and progression of human cancer. Virchows Arch. 2005;446:475–82.CrossRefPubMed
84.
Moon J-H, Eo SK, Lee JH, et al. Quercetin-induced autophagy flux enhances TRAIL-mediated tumor cell death. Oncol Rep. 2015;34:375–81.CrossRefPubMed
85.
Lawson LD, Wang ZJ. Low allicin release from garlic supplements: a major problem due to the sensitivities of alliinase activity. J Agric Food Chem. 2001;49:2592–9.CrossRefPubMed
Metadata
Title
A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer
Authors
Atousa Haghi
Haniye Azimi
Roja Rahimi
Publication date
01-12-2017
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 4/2017
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-017-9997-7

Other articles of this Issue 4/2017

Journal of Gastrointestinal Cancer 4/2017 Go to the issue

Original Research

Surgical Management of Metastatic Colorectal Cancer: A Single-Centre Experience on Oncological Outcomes of Pulmonary Resection vs Cytoreductive Surgery and HIPEC

Review Article

Expending Role of Microsatellite Instability in Diagnosis and Treatment of Colorectal Cancers

Original Research

Impact of Increased Visceral Fat Measured by CT on Colon Adenocarcinoma Stage

Original Research

Platelet Distribution Width as a Predictor of Metastasis in Gastric Cancer Patients

Review Article

Neuroendocrine Tumors of the Esophagus: State of the Art in Diagnostic and Therapeutic Management

Correction

Correction to: Hepatocellular Carcinoma with Bone Metastases: Incidence, Prognostic Significance, and Management—Single-Center Experience

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits